Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- MURANO
A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Cancer Leukemia Chronic Lymphocytic Leukemia
Study results
LPS GO28667 MURANO Final Results September 2023 English
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Danish
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Belgium Dutch
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Netherlands Dutch
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 French
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 German
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Hungarian
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Italian
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Korean
(PDF, 0.5 MB)
LPS GO28667 MURANO Final Results September 2023 Polish
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Russian
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Spanish
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Swedish
(PDF, 0.3 MB)
LPS GO28667 MURANO Final Results September 2023 Traditional Chinese
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com